World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
17050
World Ranking
2334
National Ranking
92

Overview

Renato Mantegazza is affiliated with the Istituto Neurologico Carlo Besta in Italy. Their research primarily focuses on the field of Medicine, with a significant body of work in Neurology as a major subfield. Additional research interests include Molecular Biology, Genetics, Infectious Diseases, and Oncology.

The scientist's main topics of investigation encompass Myasthenia Gravis and Thymoma, Peripheral Neuropathies and Disorders, Parkinson's Disease and Spinal Disorders, Neurogenetic and Muscular Disorders Research, Cancer Treatment and Pharmacology, Antifungal resistance and susceptibility, and Multiple Sclerosis Research Studies.

Renato Mantegazza has contributed publications to several journals and venues. The most frequent among these include:

  • Neurology
  • Neuromuscular Disorders
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of the Neurological Sciences
  • Journal of Neurology

Frequent collaborators in research efforts are:

  • Tuan Vu
  • James F. Howard
  • Kimiaki Utsugisawa
  • Vera Bril
  • Lorenzo Maggi

Renato Mantegazza's recent publications include:

  • Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial, 2021, The Lancet Neurology
  • Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study, 2023, The Lancet Neurology
  • Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study, 2023, The Lancet Neurology
  • Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis, 2022, NEJM Evidence
  • Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3, 2020, Journal of Neurology Neurosurgery & Psychiatry

Best Publications

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai

  • Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis

    Ezio Gerdoni;Barbara Gallo;Simona Casazza;Silvia Musio

  • A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

    P. Zisimopoulou;P. Evangelakou;J. Tzartos;K. Lazaridis

  • Cytokines and chemokines are both expressed by human myoblasts: Possible relevance for the immune pathogenesis of muscle inflammation

    Marco De Rossi;Pia Bernasconi;Fulvio Baggi;Renè de Waal Malefyt

  • Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses

    Chiara Verpelli;Elena Dvoretskova;Cinzia Vicidomini;Francesca Rossi

  • GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen’s encephalitis

    Heinz Wiendl;C. G. Bien;P. Bernasconi;B. Fleckenstein

  • Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.

    Renato Mantegazza;Pia Bernasconi;Fulvio Baggi;Roberto Spreafico

  • Experience with immunomodulatory treatments in Rasmussen’s encephalitis

    Tiziana Granata;L. Fusco;G. Gobbi;E. Freri

  • Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection.

    R Mantegazza;F Andreetta;P Bernasconi;F Baggi

  • Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy

    Francesca Andreetta;Pia Bernasconi;Fulvio Baggi;Paolo Ferro

  • Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus

    Paola Cavalcante;Barbara Serafini;Barbara Rosicarelli;Lorenzo Maggi

  • Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

    Paolo Confalonieri;Laura Oliva;Francesca Andreetta;Rossella Lorenzoni

  • A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy

    R. Mantegazza;E. Beghi;E. Beghi;D. Pareyson;C. Antozzi

  • Long-term selective IgG immunoadsorption improves Rasmussen's encephalitis

    Carlo Antozzi;T. Granata;N. Aurisano;G. Zardini

  • Increased Expression of β-Chemokines in Muscle of Patients with Inflammatory Myopathies

    Paolo Confalonieri;Pia Bernasconi;Paola Megna;Silvia Galbiati

  • Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN‐γ

    R. Mantegazza;S. M. Hughes;D. Mitchell;M. Travis

  • Etiology of myasthenia gravis: Innate immunity signature in pathological thymus

    Paola Cavalcante;Perrine Cufi;Renato Mantegazza;Sonia Berrih-Aknin

  • LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

    John S. Tzartos;Paraskevi Zisimopoulou;Michael Rentzos;Nikos Karandreas

  • Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies

    C. Cappelletti;F. Baggi;F. Zolezzi;D. Biancolini

  • Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience

    Lorenzo Maggi;Francesca Andreetta;Carlo Antozzi;Fulvio Baggi

  • Breakdown of Tolerance to a Self-Peptide of Acetylcholine Receptor α-Subunit Induces Experimental Myasthenia Gravis in Rats

    Fulvio Baggi;Andrea Annoni;Federica Ubiali;Monica Milani

Frequent Co-Authors

Marina Mora
Marina Mora Istituto Neurologico Carlo Besta
Matilde Leonardi
Matilde Leonardi Istituto Neurologico Carlo Besta
Socrates J. Tzartos
Socrates J. Tzartos Institut Pasteur
Roberto Spreafico
Roberto Spreafico Istituto Neurologico Carlo Besta
Renato Longhi
Renato Longhi National Academies of Sciences, Engineering, and Medicine
Tiziana Granata
Tiziana Granata Istituto Neurologico Carlo Besta
Sonia Berrih-Aknin
Sonia Berrih-Aknin Université Paris Cité
Ettore Beghi
Ettore Beghi Mario Negri Institute for Pharmacological Research
Lawrence Steinman
Lawrence Steinman Stanford University
Giuseppe Lauria
Giuseppe Lauria University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open up diverse career opportunities in healthcare and research. Many professionals begin with foundational nursing programs, and for beginners, there are excellent online nursing programs for non nurses that provide a solid entry point into patient care and biological sciences.

If you already have experience or a degree in another field, accelerated pathways like the easiest accelerated nursing programs offer a streamlined route to becoming a registered nurse. These programs are designed to balance rigorous training with manageable admission criteria, helping you move quickly toward your goals.

For those seeking quicker certifications, the fastest and easiest lpn programs provide practical nursing training in a shorter time frame. These can be valuable stepping stones for gaining hands-on experience while continuing education in immunology or related disciplines.

Advanced practice nurses aiming to specialize may benefit from easy nurse practitioner programs to get into. These programs often focus on specific populations or clinical areas, allowing you to combine clinical expertise with immunological knowledge for impactful healthcare roles.

Best Scientists Citing Renato Mantegazza

Trending Scientists